Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
When reporting injections in the facility setting, consider the following: You may report 96372 in the facility without the physician present
Vitamin B12 injection schedules B12 injection schedules typically depend on the severity of deficiency and individual response: Initial treatment: May involve daily or weekly injections until levels normalize Maintenance: Often involves monthly injections, but can vary from every 1-3 months Lifelong therapy: Some individuals may require ongoing B12 injections indefinitely Your healthcare provider will monitor your B12 levels and adjust the injection schedule accordingly
This option is particularly valuable for those who struggle with conditions that impair nutrient absorption or need rapid results